Abstract
Background: Helicobacter spp. are gastric or enterohepatic bacteria that can be commensal, opportunistic, or pathogenic. Few studies have evaluated Helicobacter spp. in baboons. Methods: Twenty‐seven captive baboons were surveyed for Helicobacter spp. by fecal PCR, and a subset evaluated by culture. Nine baboons were treated with oral “triple therapy” with clarithromycin (10 mg/kg), amoxicillin (10 mg/kg), and omeprazole (20 mg) once daily for 10 days. Results: All baboons were positive for Helicobacter spp., including H. macacae (78%), H. suis (19%), and H. pylori (15%). Three novel Helicobacter species were identified by whole genomic sequencing, for which we propose the names Helicobacter papionis , H. simiae , and H. papionifaecis. Treatment was safe and effective for H. pylori , H. suis , and H. macacae , but did not eliminate the novel Helicobacter spp. Conclusions: Species‐specific assays should guide treatment of Helicobacter spp. infections in baboons. Further epidemiologic studies are needed to inform clinical management.
Funding Information
  • National Institutes of Health (R35 CA210088)
  • National Institutes of Health (1R01 CA281732‐01)
  • National Institutes of Health (T32 OD011089)
  • Massachusetts Institute of Technology

This publication has 62 references indexed in Scilit: